CURR News and Press, Cure Pharmaceutical Holding Corp From 01/05/21

The FDA has signed off CURE Pharmaceutical's (CURR) Investigational New Drug application for its CUREfilm Blue, an oral soluble film of sildenafil citrate (the active ingredient present in Viagra) for the treatment of erectile dysfunction.The company is seeking approval of this product via th...

CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a technology focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the U.S. Food an...

2020 saw increases of 80% in Canada and expectations are for that to double next year. California will lead revenue growth rates as the state continues to ramp up the industry. Washington and Colorado are starting to see overall growth rates slow modestly, excepting pandemic-induc...

Several mergers have been announced over the past few days and this has driven cannabis stocks upwards. A newer industry is still seeing tremendous growth rates in QoQ revenues. Keeping an eye on the fastest growing revenue stocks may be key to increasing profits in investments. ...

The cannabis industry has sold off significantly over the past 12-18 months, leaving some stocks significantly undervalued on a book/price metric. Cannabis stocks are starting to push upwards again as some companies near profitability and certain metrics will provide information for i...

Cannabis stocks are seeing catalyst movements upwards with the recent legalization of some 50% MoM; MJ ETF is not adequate in following the top stocks for cannabis; Putting together a portfolio with a tracker to follow upward movements in cannabis industry. For further detai...

CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTCQB: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, today announced that management will present on the company at the LD Micr...

Nicole Kidman Partners With Sera Labs A CURE Pharmaceutical Company As A Strategic Business Partner And Global Brand Ambassador LOS ANGELES , Dec. 10, 2020 /PRNewswire/ -- The Sera Labs Inc., a wholly owned subsidiary of CURE Pharmaceutical Holdings (OTCQB: CURR) has...

SeraLabs is a Leading CBD Health, Wellness & Beauty Company Kidman’s partnership is exclusively with SeraLabs Topicals CURE Pharmaceutical Holdings (OTCQB: CURR) wholly owned subsidiary, The SeraLabs, Inc., has enlisted Oscar, Golden Globe and Emmy Awa...

CURE Pharmaceutical Holdings (“CURE” or the “Company”) (OTC: CURR), a holding company focused on the innovation of pharmaceutical technology, wellness products and drug delivery, announced today that it has issued a letter to its shareholders providing co...